Bluepharma
Gabriel Silva has extensive experience in the pharmaceutical industry, currently serving as the Product Development Director and previously as the Head of Galenical Development at Bluepharma since January 2009. Responsibilities primarily include leading the Product Development Team, overseeing the coordination and management of pharmaceutical development activities, optimizing dosage forms, managing scale-up and validation processes, ensuring technology transfer, and implementing continuous product and process improvements using a Risk Based and Quality by Design approach, as well as preparing EMA and FDA ANDA dossiers. Prior to this role, Gabriel worked as a Research Fellow in Product Development at Bluepharma Ind. Pharm. S.A. from September 2004 to January 2009, focusing on the development of solid and liquid pharmaceutical dosage forms. Gabriel holds a Doctor of Pharmacy degree from Faculdade de Farmacia Universidade de Coimbra and completed a postgraduate program in business management at Porto Business School in 2015.
This person is not in any teams
Bluepharma
Bluepharma Group is today one of the most entrepreneurial and innovative in the pharmaceutical sector, having already achieved a remarkable prestige not only in Portugal, but also in the most demanding international markets. Throughout its 20 years, Bluepharma has transformed an industrial unit that employs 58 people, in an economic group of 20 companies and more than 700 employees. It has opened offices in 4 countries (Spain, Angola, Mozambique and USA) and exported, in 2020, 88% of its production to more than 40 countries. Bluepharma's activity goes through the entire value chain of the drug, from R&D to the market, imposing itself for the excellence of its production unit, the quality and training of its employees and the experience and dynamism of its management team.